Pennsylvania Hospitals Unite, Calling on Communities to “Protect the Heroes”

Pennsylvania Hospitals Unite, Calling on Communities to “Protect the Heroes”

Guthrie and Geisinger are coming together to spotlight a new national initiative encouraging people to support their local hospitals on the front lines of the COVID-19 pandemic. The Protect the Heroes campaign was created to raise funds for critical hospital resources, including hundreds of millions of masks and other materials for the physicians, nurses, and caregivers who are treating coronavirus patients and are at greater risk due to a nationwide shortage of PPE.

Joseph Scopelliti, MD, Guthrie President and CEO said, “The COVID-19 pandemic will have financial consequences for our hospitals. A donation to your local hospital, through the Protect the Heroes campaign, ensures all facilities have the supplies they need to treat the communities we serve during these unprecedented times.”

Individuals can visit www.ProtectTheHeroes.org and, with a single click, be connected to the website of a local hospital of their choosing and contribute to hospital emergency relief funds. Hospitals face severe shortages of all forms of PPE and have multiple financial needs related to COVID-19.

“Our teams are on the front lines fighting the COVID-19 pandemic in our local communities,” said J. Edward Hartle, MD, Geisinger’s executive vice president and chief medical officer. “We need you to be a part of that fight. Your donations are critical to helping us care for more of your family, friends and neighbors. We’re here for you. Thank you for being there for us.”

The Creative Coalition launched #ProtectTheHeroes with the Association for Healthcare Philanthropy and the American Hospital Association to help frontline hospital workers win the fight against coronavirus. Every dollar raised from Protect the Heroes goes directly to the donor’s choice of a local hospital to purchase personal protective equipment (PPE) and other support for their local healthcare workers to fight COVID-19.